SupplierRadar
Sign inStart free

PT. Nusantara Jaya Abadi

FDA import alert and refusal historyJakarta, IndonesiaFEI 3007146732

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on PT. Nusantara Jaya Abadi.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectPT. Nusantara Jaya Abad added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, PT. Nusantara Jaya Abadi (Jakarta, Indonesia) is on the red list of FDA Import Alert 16-120 (Seafood from processors not in compliance with HACCP) for tuna, published by FDA on April 24, 2018, is also listed on Import Alert 16-81 (red list), and has 4 FDA import refusals recorded since October 2016.

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
IA 16-120 · red listIA 16-81 · red list
Last import refusal
Tuna (albacore, yellowfin, bluefin, skipjack, etc.) · SALMONELLA
Last warning letter
None found
Last inspection
None on record

Every FDA record for PT. Nusantara Jaya Abadi

6 records, newest first. Each line links to the FDA page it came from.

2018

  1. Import alert listing
    Listed on Import Alert 16-120red listTuna
    Source
  2. Import refusal
    Refused, Tuna (albacore, yellowfin, bluefin, skipjack, etc.)SALMONELLAEntry 406-0542085-6
    Source

2017

  1. Import refusal
    Refused, 3 lines in one entry: Tuna (albacore, yellowfin, bluefin, skipjack, etc.)SALMONELLAEntry KM6-3509195-2Show 3 lines
    • Refused, Tuna (albacore, yellowfin, bluefin, skipjack, etc.)SALMONELLAEntry KM6-3509195-2Source
    • Refused, Tuna (albacore, yellowfin, bluefin, skipjack, etc.)SALMONELLAEntry KM6-3509195-2Source
    • Refused, Tuna (albacore, yellowfin, bluefin, skipjack, etc.)SALMONELLAEntry KM6-3509195-2Source
    Source
  2. Import alert listing
    Listed on Import Alert 16-81red listTuna
    Source

Refusal charges, in plain English

  • SALMONELLA4 refused lines

    Salmonella

    The product appeared to contain Salmonella, which the law treats as a poisonous and deleterious substance that may make food injurious to health.

Questions about PT. Nusantara Jaya Abadi

Is PT. Nusantara Jaya Abadi on an FDA import alert?
Yes. As of October 26, 2026, PT. Nusantara Jaya Abadi is on the red list of FDA Import Alert 16-120, “Seafood from processors not in compliance with HACCP”, for tuna; FDA published the listing on April 24, 2018.
Has FDA refused shipments from PT. Nusantara Jaya Abadi?
Yes. FDA refused 4 shipment lines from PT. Nusantara Jaya Abadi between December 14, 2017 and March 12, 2018. The most recent, on March 12, 2018, was tuna (albacore, yellowfin, bluefin, skipjack, etc.), charged as SALMONELLA (salmonella).
Why did FDA refuse PT. Nusantara Jaya Abadi's shipments?
The most frequent charge is SALMONELLA (salmonella, 4 lines).
What is PT. Nusantara Jaya Abadi's FEI number?
PT. Nusantara Jaya Abadi's FDA Establishment Identifier (FEI) is 3007146732.
Can shipments from PT. Nusantara Jaya Abadi still enter the U.S.?
Shipments of tuna from PT. Nusantara Jaya Abadi can be detained without physical examination under Import Alert 16-120; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).

Buying from PT. Nusantara Jaya Abadi?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on PT. Nusantara Jaya Abadi.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectPT. Nusantara Jaya Abad added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.